UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q4 2020 | 2021-02-10 | Future report Set alerts | |
| Q3 2020 | 2020-10-28 | Future report Set alerts | |
| Q2 2020 | 2020-07-27 | 0.01 | 0.01 |
| Q1 2020 | 2020-04-30 | 0.01 | 0.01 |
| Q4 2019 | 2020-02-12 | -0.10 | -0.10 |
| Q3 2019 | 2019-10-24 | 0.11 | 0.10 |
| Q2 2019 | 2019-08-20 | 0.06 | 0.05 |
| Q1 2019 | 2019-04-25 | 0.03 | -0.02 |
| Q4 2018 | 2019-02-07 | -0.02 | -0.04 |
| Q3 2018 | 2018-10-25 | 0.10 | 0.12 |
| 2016-06-16 | Upgrade | Scotiabank | Sector Perform to Sector Outperform | |
| 2016-05-16 | Reiterated Rating | Sterne Agee CRT | Buy | |
| 2016-04-27 | Downgrade | Citigroup Inc. | Buy to Neutral | |
| 2016-04-21 | Upgrade | Barclays | Equal Weight to Overweight | $6.00 to $10.00 |
| 2016-04-21 | Upgrade | Barclays PLC | Equal Weight to Overweight | $6.00 to $10.00 |
| 2016-04-06 | Downgrade | Scotiabank | Outperform to Sector Perform | |
| 2016-03-21 | Upgrade | BB&T Corp. | Hold to Buy | $9.00 |
| 2016-03-20 | Reiterated Rating | Jefferies Group | Buy | $8.00 |
| 2016-03-18 | Upgrade | Credit Suisse | Neutral to Outperform | $6.00 to $7.80 |
| 2016-03-18 | Upgrade | Credit Suisse Group AG | Neutral to Outperform | $6.00 to $7.80 |
| 2016-03-09 | Boost Price Target | Santander | Hold | $6.10 to $7.00 |
| 2016-02-16 | Boost Price Target | BNP Paribas | Neutral | $5.70 to $8.00 |
| 2016-02-08 | Reiterated Rating | Jefferies | Buy | $7.00 to $8.00 |
| 2016-02-08 | Reiterated Rating | Jefferies Group | Buy | $7.00 to $8.00 |
| 2016-02-05 | Boost Price Target | Jefferies Group | Buy | $7.00 to $8.00 |
| 2016-02-05 | Lower Price Target | Goldman Sachs | Buy | $8.50 to $7.00 |
| 2016-02-05 | Lower Price Target | Goldman Sachs Group Inc. | Buy | $8.50 to $7.00 |
| 2016-02-02 | Upgrade | Citigroup Inc. | Neutral to Buy | |
| 2016-01-29 | Upgrade | Jefferies Group | Hold to Buy | $8.00 to $7.00 |
| 2016-01-28 | Reiterated Rating | JPMorgan Chase & Co. | Buy | |
| 2016-01-25 | Lower Price Target | Barclays | Equal Weight | $9.00 to $6.00 |
| 2016-01-08 | Downgrade | Macquarie | Outperform to Neutral | $18.00 to $7.30 |
| 2015-12-17 | Reiterated Rating | JPMorgan Chase & Co. | Buy | |
| 2015-12-14 | Downgrade | Credit Suisse | Outperform to Neutral | $11.00 to $6.00 |
| 2015-10-27 | Downgrade | Santander | Buy to Hold | $15.50 to $8.80 |
| 2015-10-23 | Lower Price Target | BNP Paribas | Neutral | $9.50 to $8.50 |
| 2015-10-23 | Downgrade | Barclays | Overweight to Equal Weight | $12.00 to $9.00 |
| 2015-10-22 | Downgrade | Citigroup Inc. | Buy to Neutral | |
| 2015-10-14 | Lower Price Target | Jefferies Group | Hold | $9.00 to $8.00 |
| 2015-10-13 | Lower Price Target | Scotiabank | $10.90 to $10.50 | |
| 2015-09-23 | Lower Price Target | HSBC | Buy | $11.90 to $10.15 |
| 2015-09-17 | Lower Price Target | Scotiabank | $13.00 to $10.90 | |
| 2015-09-02 | Lower Price Target | BNP Paribas | $9.50 | |
| 2015-07-23 | Reiterated Rating | Sterne Agee CRT | Buy | $13.00 |
| 2015-07-23 | Lower Price Target | Barclays | Overweight | $13.00 to $12.00 |
| 2015-07-02 | Reiterated Rating | Barclays | Overweight | $13.00 |
| 2015-05-27 | Upgrade | Longbow Research | Neutral to Buy | $12.00 |
| 2015-01-30 | Downgrade | Longbow Research | Buy to Neutral | |
| 2015-01-27 | Lower Price Target | Barclays | Overweight | $14.00 to $13.00 |
| 2015-01-26 | Lower Price Target | JPMorgan Chase & Co. | Overweight | $14.40 to $11.70 |
| 2014-10-20 | Reiterated Rating | Jefferies Group | Hold | $14.10 to $12.80 |
| 2014-09-02 | Downgrade | BNP Paribas | Neutral to Underperform | |
| 2014-06-27 | Reiterated Rating | JPMorgan Chase & Co. | Overweight | $14.00 to $15.50 |
| 2014-06-19 | Reiterated Rating | Jefferies Group | Hold | |
| 2014-03-20 | Upgrade | Longbow Research | Neutral to Buy | |
| 2014-02-19 | Upgrade | Sterne Agee CRT | Neutral to Buy | $16.00 |
| 2014-01-22 | Reiterated Rating | Morgan Stanley | Overweight | $13.00 to $14.00 |
| 2013-06-19 | Upgrade | Barclays | Equal Weight to Overweight | $12 to $12 |
| 2012-08-27 | Upgrade | Imperial Capital | Underperform to In-line | $3.50 to $7 |
| 2012-06-28 | Initiated | Imperial Capital | Underperform | $3.50 |
| 2011-10-05 | Initiated | RBC Capital Mkts | Sector Perform | $3 |
| 2011-06-29 | Initiated | Barclays Capital | Equal Weight | $9 |
| 2010-04-28 | Initiated | Deutsche Bank | Buy | |
| 2009-08-17 | Upgrade | Deutsche Securities | Hold to Buy | $11.20 to $15 |
| 2009-03-09 | Downgrade | BB&T Capital Mkts | Buy to Hold | |
| 2008-10-09 | Downgrade | Citigroup | Buy to Hold | $31 to $13 |
| 2008-09-12 | Downgrade | Longbow | Buy to Neutral | |
| 2008-09-08 | Downgrade | Deutsche Securities | Buy to Hold |
| 2016-06-16 | Upgrade | Scotiabank | Sector Perform to Sector Outperform | |
| 2016-05-16 | Reiterated Rating | Sterne Agee CRT | Buy | |
| 2016-04-27 | Downgrade | Citigroup Inc. | Buy to Neutral | |
| 2016-04-21 | Upgrade | Barclays | Equal Weight to Overweight | $6.00 to $10.00 |
| 2016-04-21 | Upgrade | Barclays PLC | Equal Weight to Overweight | $6.00 to $10.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In CX 161 funds of 2184 total. Show all
| Fund name | Ticker shares |
|---|---|
| DODGE & COX | 0.11B |
| FMR LLC | 72.92M |
| BRANDES INVESTMENT PARTNERS, LP | 67.17M |
| BAILLIE GIFFORD & CO | 39.71M |
| UBS GLOBAL ASSET MANAGEMENT AMERICAS INC | 38.25M |
| OAKTREE CAPITAL MANAGEMENT LP | 23.94M |
| Ruffer LLP | 15.82M |
| Electron Capital Partners, LLC | 15.21M |
| DIMENSIONAL FUND ADVISORS LP | 13.29M |
| WELLS FARGO & CO/MN | 11.51M |
| RUSSELL FRANK CO/ | 10.46M |
| TT INTERNATIONAL | 8.51M |
| AMERICAN CENTURY COMPANIES INC | 7.70M |
| Nuveen Asset Management, LLC | 7.09M |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 6.55M |
Undercovermarket.com